Sagimet Biosciences Inc (SGMT)
4.34
+0.05
(+1.17%)
USD |
NASDAQ |
May 07, 16:00
4.34
0.00 (0.00%)
After-Hours: 20:00
Sagimet Biosciences Free Cash Flow: -23.77M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -23.77M |
| September 30, 2023 | -24.14M |
| June 30, 2023 | -26.49M |
| March 31, 2023 | -26.91M |
| Date | Value |
|---|---|
| December 31, 2022 | -24.49M |
| September 30, 2022 | -21.94M |
| June 30, 2022 | -18.30M |
Free Cash Flow Range, Past 5 Years
-26.91M
Minimum
Mar 2023
-18.30M
Maximum
Jun 2022
-23.72M
Average
-24.14M
Median
Sep 2023
Free Cash Flow Benchmarks
| Madrigal Pharmaceuticals Inc | -325.71M |
| 89bio Inc | -129.19M |
| Viking Therapeutics Inc | -54.87M |
| Akero Therapeutics Inc | -145.37M |
| Arrowhead Pharmaceuticals Inc | -402.70M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.083M |
| Cash from Investing (Quarterly) | -19.62M |
| Free Cash Flow Per Share (Quarterly) | -0.3094 |
| Free Cash Flow Yield | -25.64% |